About Shield Therapeutics
Data Unavailable
Country
Industry:
Founded:
2008
IPO Date:
02/26/2016
ISIN Number:
I_GB00BYV81293
Contact Details
Address:
Northern Design Centre, Baltic Business Quarter, Gateshead, Tyne and Wear, NE8 3DF, United Kingdom
Phone Number
44 1915 118 500
Key Executives
CEO:
Madison, Gregory
CFO
Shanbhag, Santosh
COO:
Data Unavailable